Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06001736 · ClinicalTrials.gov registry record · NA
Utility of CC7 Transfer in Stroke Subtypes
A NA study of Stroke, Ischemic and Stroke Hemorrhagic, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT06001736: Recruiting NA study of Stroke, Ischemic and Stroke Hemorrhagic, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06001736 is a NA study of Stroke, Ischemic and Stroke Hemorrhagic that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 95 participants, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06001736, a NA study of Stroke, Ischemic and Stroke Hemorrhagic, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
Primary Outcome
The Fugl-Meyer is a widely used and highly recommended stroke-specific, performance-based measure of impairment with 5 domains and a possible 226 points.
Conditions Studied
Interventions
- PROCEDURE Contralateral C7 root transfer for the treatment of spastic hemiparesis.
Study Locations (1)
New Hampshire
- Dartmouth-Health - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-03-13 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT06001736 shows while recruiting
NCT06001736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which Contralateral C7 root transfer for the treatment of spastic hemiparesis. is the first listed.
NCT06001736 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06001736 about?
NCT06001736 is a clinical study titled "Utility of CC7 Transfer in Stroke Subtypes". The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
What is the current status of trial NCT06001736?
This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2022-03-13. Estimated completion is 2027-03-01.
What conditions does trial NCT06001736 study?
This clinical trial studies the following conditions: Stroke, Ischemic, Stroke Hemorrhagic, Spastic Hemiparesis.
What interventions are being tested in trial NCT06001736?
The interventions under investigation include: Contralateral C7 root transfer for the treatment of spastic hemiparesis. (PROCEDURE).
Who is sponsoring clinical trial NCT06001736?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06001736 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06001736's enrollment target sits among peer trials
95 17th of 33 higher than 17 of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
RECRUITING · NA
-
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits
RECRUITING · NA
-
Effect of Visual Retraining After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI